Dexmedetomidine Alleviates Inflammation in Neuropathic Pain by Suppressing NLRP3 Via Nrf2 Activation

Overview

Journal Exp Ther Med

Specialty Pathology

Date 2021 Aug 26

PMID 34434260

Citations 11

Authors

Wenyan Shan

Xiaoyun Liao

Yixun Tang

Jitong Liu

Affiliations

Soon will be listed here.

Abstract

The aim of the present study was to investigate the mechanism by which dexmedetomidine (DEX) alleviates neuropathic pain in a chronic constriction injury (CCI) model in rats. A CCI rat model was established through sciatic nerve ligation. CCI rats were treated with DEX, the nuclear factor erythroid 2-related factor 2 (Nrf2) inhibitor ML385, the NLR family pyrin domain containing 3 (NLRP3) antagonist MCC950 and/or the NLRP3 activator nigericin. The mechanical withdrawal threshold (MWT) was measured to assess the pain sensitivity of CCI rats. Hematoxylin and eosin staining and TUNEL staining were used to examine spinal injury and apoptosis, respectively. ELISA was used to quantify the levels of inflammatory factors. The expression levels of Nrf2 and NLRP3 were also examined. The results indicated that a decrease in MWT and increases in spinal cord injury, apoptosis and inflammatory factors were detected in CCI rats compared with control rats. Spinal inflammation was abrogated in DEX-treated CCI rats. Compared with the model group, an increase in MWT and decreases in spinal cord injury, apoptosis and inflammatory factors were detected in rats treated with MCC950, while the opposite effects were observed in rats treated with nigericin. The opposite effects on these indicators were observed in the DEX + ML385 and MCC950 + ML385 groups compared with the DEX and MCC950 groups, respectively. MWT was increased, while spinal cord injury, apoptosis and inflammation decreased in the nigericin + DEX group compared with the nigericin group. In summary, the results of the present study indicated that DEX reduced neuropathic pain in CCI rats by suppressing NLRP3 through Nrf2 activation.

Citing Articles

Progress on the Mechanisms and Neuroprotective Benefits of Dexmedetomidine in Brain Diseases.

Tao Z, Li P, Zhao X Brain Behav. 2024; 14(11):e70116.

PMID: 39482839 PMC: 11527817. DOI: 10.1002/brb3.70116.

The Antinociceptive Role of Nrf2 in Neuropathic Pain: From Mechanisms to Clinical Perspectives.

Petrikonis K, Bernatoniene J, Kopustinskiene D, Casale R, Davinelli S, Saso L Pharmaceutics. 2024; 16(8).

PMID: 39204413 PMC: 11358986. DOI: 10.3390/pharmaceutics16081068.

The Role of Intravenous Anesthetics for Neuro: Protection or Toxicity?.

Wang K, Wang Y, Zhang T, Chang B, Fu D, Chen X Neurosci Bull. 2024; 41(1):107-130.

PMID: 39153174 PMC: 11748649. DOI: 10.1007/s12264-024-01265-4.

Prenatal alcohol exposure promotes NLRP3 inflammasome-dependent immune actions following morphine treatment and paradoxically prolongs nerve injury-induced pathological pain in female mice.

Noor S, Sun M, Pasmay A, Pritha A, Ruffaner-Hanson C, Nysus M Alcohol Clin Exp Res (Hoboken). 2023; 47(12):2262-2277.

PMID: 38151779 PMC: 10764094. DOI: 10.1111/acer.15214.

The Inhibition of Neuropathic Pain Incited by Nerve Injury and Accompanying Mood Disorders by New Heme Oxygenase-1 Inducers: Mechanisms Implicated.

Suarez-Rojas I, Perez-Fernandez M, Bai X, Martinez-Martel I, Intagliata S, Pittala V Antioxidants (Basel). 2023; 12(10).

PMID: 37891937 PMC: 10603856. DOI: 10.3390/antiox12101859.

References

Thimmulappa R, Lee H, Rangasamy T, Reddy S, Yamamoto M, Kensler T . Nrf2 is a critical regulator of the innate immune response and survival during experimental sepsis. J Clin Invest. 2006; 116(4):984-95. PMC: 1421348. DOI: 10.1172/JCI25790. View

Farghaly H, Mahmoud A, Abdel-Sater K . Effect of dexmedetomidine and cold stress in a rat model of neuropathic pain: Role of interleukin-6 and tumor necrosis factor-α. Eur J Pharmacol. 2016; 776:139-45. DOI: 10.1016/j.ejphar.2016.02.046. View

Tonkin R, Bowles C, Perera C, Keating B, Makker P, Duffy S . Attenuation of mechanical pain hypersensitivity by treatment with Peptide5, a connexin-43 mimetic peptide, involves inhibition of NLRP3 inflammasome in nerve-injured mice. Exp Neurol. 2017; 300:1-12. DOI: 10.1016/j.expneurol.2017.10.016. View

Wiesenfeld-Hallin Z . Sex differences in pain perception. Gend Med. 2005; 2(3):137-45. DOI: 10.1016/s1550-8579(05)80042-7. View

Kilkenny C, Browne W, Cuthill I, Emerson M, Altman D . Animal research: reporting in vivo experiments: the ARRIVE guidelines. J Gene Med. 2010; 12(7):561-3. DOI: 10.1002/jgm.1473. View

Du L, Wang J, Chen Y, Li X, Wang L, Li Y . Novel biphenyl diester derivative AB-38b inhibits NLRP3 inflammasome through Nrf2 activation in diabetic nephropathy. Cell Biol Toxicol. 2019; 36(3):243-260. DOI: 10.1007/s10565-019-09501-8. View

Jia M, Wu C, Gao F, Xiang H, Sun N, Peng P . Activation of NLRP3 inflammasome in peripheral nerve contributes to paclitaxel-induced neuropathic pain. Mol Pain. 2017; 13:1744806917719804. PMC: 5562344. DOI: 10.1177/1744806917719804. View

Ahmed S, Luo L, Namani A, Wang X, Tang X . Nrf2 signaling pathway: Pivotal roles in inflammation. Biochim Biophys Acta Mol Basis Dis. 2016; 1863(2):585-597. DOI: 10.1016/j.bbadis.2016.11.005. View

Jo E, Kim J, Shin D, Sasakawa C . Molecular mechanisms regulating NLRP3 inflammasome activation. Cell Mol Immunol. 2015; 13(2):148-59. PMC: 4786634. DOI: 10.1038/cmi.2015.95. View

10.

Castejon M, Sanchez-Hidalgo M, Aparicio-Soto M, Montoya T, Martin-Lacave I, Fernandez-Bolanos J . Dietary oleuropein and its new acyl-derivate attenuate murine lupus nephritis through HO-1/Nrf2 activation and suppressing JAK/STAT, NF-κB, MAPK and NLRP3 inflammasome signaling pathways. J Nutr Biochem. 2019; 74:108229. DOI: 10.1016/j.jnutbio.2019.108229. View

11.

Livak K, Schmittgen T . Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2002; 25(4):402-8. DOI: 10.1006/meth.2001.1262. View

12.

Zhao Y, He J, Yu N, Jia C, Wang S . Mechanisms of Dexmedetomidine in Neuropathic Pain. Front Neurosci. 2020; 14:330. PMC: 7214625. DOI: 10.3389/fnins.2020.00330. View

13.

Attal N, Bouhassira D . Pharmacotherapy of neuropathic pain: which drugs, which treatment algorithms?. Pain. 2015; 156 Suppl 1:S104-S114. DOI: 10.1097/01.j.pain.0000460358.01998.15. View

14.

Lin J, Chen C, Huang L, Li N, Yang Y, Zhu S . Dexmedetomidine Attenuates Neuropathic Pain by Inhibiting P2X7R Expression and ERK Phosphorylation in Rats. Exp Neurobiol. 2018; 27(4):267-276. PMC: 6120967. DOI: 10.5607/en.2018.27.4.267. View

15.

Arruri V, Komirishetty P, Areti A, Dungavath S, Kumar A . Nrf2 and NF-κB modulation by Plumbagin attenuates functional, behavioural and biochemical deficits in rat model of neuropathic pain. Pharmacol Rep. 2017; 69(4):625-632. DOI: 10.1016/j.pharep.2017.02.006. View

16.

Yang Y, Luo L, Cai X, Fang Y, Wang J, Chen G . Nrf2 inhibits oxaliplatin-induced peripheral neuropathy via protection of mitochondrial function. Free Radic Biol Med. 2018; 120:13-24. DOI: 10.1016/j.freeradbiomed.2018.03.007. View

17.

Xie X, Ma L, Xi K, Fan D, Li J, Zhang Q . Effects of microRNA-223 on morphine analgesic tolerance by targeting NLRP3 in a rat model of neuropathic pain. Mol Pain. 2017; 13:1744806917706582. PMC: 5464520. DOI: 10.1177/1744806917706582. View

18.

Liu X, Zhou W, Zhang X, Lu P, Du Q, Tao L . Dimethyl fumarate ameliorates dextran sulfate sodium-induced murine experimental colitis by activating Nrf2 and suppressing NLRP3 inflammasome activation. Biochem Pharmacol. 2016; 112:37-49. DOI: 10.1016/j.bcp.2016.05.002. View

19.

Lees J, Fivelman B, Duffy S, Makker P, Perera C, Moalem-Taylor G . Cytokines in Neuropathic Pain and Associated Depression. Mod Trends Pharmacopsychiatry. 2015; 30:51-66. DOI: 10.1159/000435932. View

20.

Dong Z, Shang H, Chen Y, Pan L, Bhatia M, Sun J . Sulforaphane Protects Pancreatic Acinar Cell Injury by Modulating Nrf2-Mediated Oxidative Stress and NLRP3 Inflammatory Pathway. Oxid Med Cell Longev. 2016; 2016:7864150. PMC: 5101394. DOI: 10.1155/2016/7864150. View